nav-left cat-right
cat-right

Key HIV protein structure revealed

Scientists have unraveled one of the mysteries of HIV–they’ve mapped out the structure of an envelope protein that allows the virus to get into human cells to cause infection. A team of researchers at the California campus of The Scripps Research Institute along with collaborators at the Weill Medical College of Cornell University say the breakthrough–which could provide the groundwork for developing an...

HPV Vaccine Benefits Women with HIV

A vaccine for human papillomavirus (HPV) may benefit women with HIV, even if they have already been exposed to HPV, according to a study released by an NIH research network. The study, published in the Journal of Acquired Immune Deficiency Syndromes in an article titled “Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination”, notes that more than 45% of women...

HTLV blood screening test from RTP diagnostics fir...

The U.S. Food and Drug Administration has approved a new test for blood donations, just the second test available to screen for two viruses linked to leukemia and neurologic disorders. The blood test, developed by medical device company Avioq, detects antibodies to human T-lymphotropic virus type 1 (HTLV 1) and human T-lymphotropic virus type 2 (HTLV 2). In addition to screening blood donors for the presence of the viruses,...

LABS, Inc. Launches Suite of Next-Generation Test ...

CENTENNIAL, Colo., March 21, 2012 /PRNewswire via COMTEX/ — LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, this month launches a group of new laboratory tests suitable for screening complex biologic products. These new offerings will allow the company to provide innovative...

Research at A&M and Scripps finds HIV-killing...

COLLEGE STATION – A powerful topical preventative for HIV, the virus that causes AIDS, could be a step closer to clinical trials, thanks to a newly discovered molecular compound that research at Texas A&M University and the Scripps Research Institute shows dissolves the virus on contact. The ability of the synthetic compound known as “PD 404,182” to break apart the AIDS-causing virus before it can...

Body & Mind – HEALTH U.S. Doctor Cautio...

A New York City-based infectious disease specialist said a new vaccine developed by Spanish scientists, which could turn HIV into minor infection status, is reason to be cautiously optimistic. Dr. Joseph Rahimian said Thursday news of an HIV vaccine is certainly exciting, but questions remain. “An HIV vaccine has been the holy grail for infectious disease doctors for a very long time,” Rahimian said. “ There are a...
Page 2 of 712345...Last »